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Cerebral inflammatory responses may initiate secondary cascades following traumatic
brain injury (TBI). Changes in the expression of both cytokines and chemokines may
activate, regulate, and recruit innate and adaptive immune cells associatedwith secondary
degeneration, as well as alter a host of other cellular processes. In this study, we quantified
the temporal expression of a large set of inflammatory mediators in rat cortical tissue
after brain injury. Following a controlled cortical impact (CCI) on young adult male rats,
cortical and hippocampal tissue of the injured hemisphere and matching contralateral
material was harvested at early (4, 12, and 24 hours) and extended (3 and 7 days) time
points post-procedure. Naïve rats that received only anesthesia were used as controls.
Processed brain homogenates were assayed for chemokine and cytokine levels utilizing
an electrochemiluminescence-based multiplex ELISA platform. The temporal profile of
cortical tissue samples revealed a multi-phasic injury response following brain injury.
CXCL1, IFN-γ, TNF-α levels significantly peaked at four hours post-injury compared to
levels found in naïve or contralateral tissue. CXCL1, IFN-γ, and TNF-α levels were then
observed to decrease at least 3-fold by 12 hours post-injury. IL-1β, IL-4, and IL-13 levels
were also significantly elevated at four hours post-injury although their expression did
not decrease more than 3-fold for up to 24 hours post-injury. Additionally, IL-1β and IL-4
levels displayed a biphasic temporal profile in response to injury, which may suggest their
involvement in adaptive immune responses. Interestingly, peak levels of CCL2 and CCL20
were not observed until after four hours post-injury. CCL2 levels in injured cortical tissue
were significantly higher than peak levels of any other inflammatory mediator measured,
thus suggesting a possible use as a biomarker. Fully elucidating chemokine and cytokine
signaling properties after brain injury may provide increased insight into a number of
secondary cascade events that are initiated or regulated by inflammatory responses.
Keywords: traumatic brain injury, cytokines, inflammation, IL -8, inflammatory response
INTRODUCTION
Traumatic brain injury (TBI) costs the healthcare industry over
$6 billion annually in the US, and is a leading cause of death and
disability (Finkelstein et al., 2006). Both the primary immediate
insult, and the delayed secondary injury cascade of biochem-
ical and metabolic pathological events, cause focal and global
neurological dysfunction associated with TBI. The onset of sec-
ondary injuries, which include impaired aerobic metabolism,
altered calcium homeostasis, disrupted amino acid metabolism,
and activated inflammatory responses can be delayed for min-
utes to hours and persist for weeks to months, resulting in
damage far worse than the initial injury (He et al., 2004; Alves
et al., 2005; Bartnik et al., 2007; Faria et al., 2007; Deshpande
et al., 2008; Lloyd et al., 2008; Sun et al., 2008; Scafidi et al.,
2009; Wei et al., 2009; Xing et al., 2009; Cole et al., 2010).
Therefore, major research effort has been invested in therapeu-
tic interventions during secondary events (Arcure and Harrison,
2009; Xiong et al., 2009; Adeleye et al., 2010; Ziebell and
Morganti-Kossmann, 2010). However, the underlying cause(s) of
these complex post-traumatic effects has yet to be completely
determined.
Post-traumatic inflammatory responses, including increased
cytokine expression and microglial activation, have received
increasing attention as both biomarkers and potential drivers
of post-TBI. Several investigators described the spatio-temporal
accumulation of cytokines, and suggested that the post-traumatic
inflammatory response may be a key mediator of the secondary
effects. Most recently, using a fluid percussion injury model
in rats Mukherjee et al. (2011) reported a comparison of two
techniques for quantifying cytokine expression. When quantified
24 hours after injury, seven of the 23 tested cytokines demon-
strated significantly elevated concentrations in the ipsilateral cor-
tex (Mukherjee et al., 2011). While their study focused primarily
on the comparison of a Bio-Plex assay versus a new MAGPIX
assay, these results do support the findings of several other studies.
Notably, Harting et al. (2008) described significant increases in
the expression of several pro-inflammatory cytokines after a brain
injury in rats (Harting et al., 2008). Of the parameters tested,
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including interleukin-1 alpha (IL-1α), interleukin-1 beta (IL-1β),
interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-α),
all returned to baseline levels within 48 hours of injury. Other
researchers have also described a rapid response of cytokines to
injury. Notably, interleukin-1 (IL-1) is released within 60 min-
utes of injury and peaks between three hours and two days later
(Fassbender et al., 2000; Kinoshita et al., 2002). Interestingly,
the increased expression of IL-1 protein precedes an increase in
mRNA expression in injured tissue. This suggests that increases
in specific cytokines in the brain may not be exclusively gener-
ated locally, but may be part of a systemic response delivering
cytokines to the effected regions. Other laboratories have reported
a more heterotypic response in brain tissue, with increased IL-
1 and IL-6 not being observed until six hours after injury, but
with elevations in TNF-α within one hour of injury (Tehranian
et al., 2002). In yet another study, interleukin-18 (IL-18) concen-
trations in brain tissue homogenates reached significantly higher
levels seven days post-trauma (Yatsiv et al., 2002). Karaoglan et al.
(2011) reported the interesting result that increasing the sever-
ity of a controlled cortical impact (CCI) injury resulted in only
a minor increase in IL-1β, IL-6, and TNF-α (Karaoglan et al.,
2011). However, these data were collected 1, 3, and 5 days after
injury. Using human brain microdialysates, Helmy et al. (2009,
2011) provides convincing evidence of the significant contribu-
tion of locally generated cytokines, while suggesting that systemic
cytokine production plays, at best, a secondary role (Helmy et al.,
2009, 2011).
Despite preliminary evidence for potent inflammatory
responses following brain injury, it remains unknown whether
these responses are protective, neutral, damaging, or a combina-
tion over time. Proper characterization of potential mechanisms
by which inflammatory responses exacerbate the pathophysiology
of TBI requires a thorough understanding of the temporal profile
of the expression of key cytokines. While excellent work has been
performed using a variety of models, we chose to evaluate the
temporal profile of cytokine accumulation in injured rat brain
cortex using a technique with greatly improved sensitivity. These
results can thus be readily compared to the results of research
examining cortical changes in metabolism, calcium homeostasis,
protein expression, and a host of other topics. Results of this
study, when combined with results of studies examining other
post-traumatic changes, may provide insights into underlying
causes of secondary injuries.
MATERIALS AND METHODS
ANIMAL SUBJECTS
All experiments were performed on adult male (10–12 week
old, 250–275 g) Sprague–Dawley rats obtained from Taconic
Farms (Germantown, NY). All procedures were approved by the
Uniformed Services University of the Health Sciences Institution
for Animal Care and Use Committee (IACUC) in accordance with
international guidelines on the ethical use of animals. Animals
weremaintained in a normal 12 hour light:dark cycle, with ad libi-
tum access to both feed and water. The 30 rats were assigned
randomly to one of two groups—a control group (n = 5) that
was placed in the stereotax and received anesthesia only (con-
trol), and a brain injured group (TBI). The TBI group was further
distributed randomly to one of five time points with five rats each
(4, 12, or 24 hours, and 3 or 7 days) for sacrifice post-surgery and
comparison to control animals. Previously, we have shown that a
craniotomy itself induces a potent inflammatory response, and so
the most appropriate control model, to insure accurate baseline
cytokine values is a rat that receives only anesthesia (Cole et al.,
2011).
TRAUMATIC BRAIN INJURY PROCEDURE
Rats were induced with 4% isoflurane andmaintained with 2% in
98% O2. The vented anesthesia chamber and stereotactic device,
which delivered anesthesia via nose cone, were connected to a
scrubber. Throughout the following procedure, the depth of seda-
tion was monitored by absent response to toe-pinch. The surgical
site was prepared by shaving the top of the animal’s head, followed
by three successive swab applications of 95% ethanol and beta-
dine. The rat was then placed in the stereotactic device, and head
held in a horizontal position by placement of blunt-tipped inter-
aural and incisor bars. The remainder of the procedure used asep-
tic techniques. A midline scalp incision exposed the skull. After
using the stereotactic device to determine the correct location for
the craniotomy (+5.2 lambda, +3.5 lateral left), a craniotomy
was performed using a 5.2mm inner diameter trephine bit (Ace
Surgical Supply Company, Brockton, MA) attached to a variable
speed micrometer drill (Dremel, Racine, WI). After formation of
the 6mmbone flap, the tip of the scalpel was gently placed against
the bone flap at an oblique angle to prevent inadvertent damage to
the brain, and the flap lifted and removed. A digitally controlled
CCI (MyNeuroLab, Richmond, IL) plunger was then moved into
position directly above the craniotomy to allow plunger baseline
setting and centering, and then impact delivered. The ipsilateral
side is defined as the side receiving the impact. The contralateral
side is the identical region of cortex in the opposite hemisphere of
the brain. The plunger velocity (5m/s), diameter (5mm), impact
depth (2mm), and dwell time (100ms) were previously cali-
brated to deliver a moderate to severe brain injury. After the
bone flap was replaced and secured with bone wax, the incision
was sutured using 4-0 nylon monofilament (Ethicon, Somerville,
NJ). Alternatively, control (naïve) animals were anesthetized and
placed in the stereotax for 22 minutes, which is the same length
of time as the average CCI procedure, but did not undergo a scalp
incision or receive craniotomy. After the procedure, all animals
were returned to a recovery cage and continuously monitored
until they were bright, alert and responsive (BAR). Recovery time
was typically less than 10 minutes, at which time, the rats were
returned to their home cage.
TISSUE COLLECTION
At the appropriate time points post-injury, cortical tissues were
grossly dissected at the location of cortical impact. Tissue was
weighed in the receiving tube and homogenized in 10 volumes
per weight of T-Per Extraction Buffer (Pierce Biotechnology,
Rockford, IL) with added Halt protease inhibitor (Pierce
Biotechnology) utilizing a Biorupter UCD-200 ultrasonic dis-
rupter (Diagenode, Sparta, NH). Homogenates were centrifuged
at 10,000× g for 10 minutes at 4◦C. Supernatants were trans-
ferred to new tubes and used for analysis. Protein concentration
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of samples was quantified with a Bradford Protein Assay Kit
(Bio-Rad, Hercules, CA).
ELECTROCHEMILUMINESCENT IMMUNOASSAY ANALYSIS OF
CHEMOKINES AND CYTOKINES
Analyte levels in cortical homogenates were measured using a
combination of singleplex and multiplex electrochemilumines-
cent immunoassays. Specifically, the Multi-Array Rat Cytokine
Ultra-Sensitive 7-Plex Assay, the Rat MCP-1 Ultra-Sensitive Kit,
and a Rat MIP-3a Ultra-Sensitive 4-Plex Assay (Meso Scale
Discovery, Gaithersburg, MD) were utilized in this study. All
assays were performed at the same time with the one aliquot
of cortical homogenate sample. Standard curves were present
on all plates and performed in triplicate, and blank wells were
performed with five technical replicates. Experimental samples
were performed in duplicate. During the procedure, plates were
washed using the BioTek ELx405 Select automated liquid han-
dling platform. Imaging of the plates was performed using a
Sector 6000 Imager (Meso Scale Discovery). A standard curve for
each analyte was curve-fitted and allowed determination of the
concentration in pg cytokine/mL sample volume in each well,
which was normalized to total protein input to calculate ana-
lyte amount in pg cytokine/mg total protein. The lower limits
of detection for each cytokine were calculated from curve-fitted
values in blank wells + 2.5 SDs and are provided in Table 1.
STATISTICAL ANALYSIS
Collected data were analyzed via ANOVA using SigmaStat (Systat
Software, Chicago, IL). When normality tests failed, a Kruskal
Wallis ANOVA on Ranks was performed. Significance was based
on two-tailed tests, with p < 0.05. For post hoc comparisons,
Holm–Sidak tests were used. Concentrations of interferon gamma
(IFN-γ) in the control and contralateral tissue were below
detectable limits, and so no statistical analyses were performed
on this analyte. Data analysis was performed at the conclusion of
the project, after all results were collected.
RESULTS
ACUTE CYTOKINE CORTICAL RESPONSE TO TRAUMATIC BRAIN
INJURY
Within four hours of the CCI, eight of the nine cytokines
tested for were significantly increased in ipsilateral cortex as
compared to levels measured in naïve control cortical tissue.
Table 1 | Lower limits of detection at 95% confidence.
Analyte pg/mL
CXCL1(KC/GRO) 0.433
TNF-α 0.68
CCL2 (MCP-1) 0.66
IL-1β 3.1
CCL20 (MIP-3a) 11.4
IL-13 1.34
IL-4 1.22
IL-5 2.01
IFN-γ 3.20
Of these eight, five peaked in expression at four hours, while
subsiding to baseline levels within seven days. In TBI ipsilat-
eral cortex, chemokine C-X-C motif ligand 1 (CXCL1) signif-
icantly (p < 0.001) increased from 0.74 ± 1.21 pg/mg protein
in control cortex to 175.02 ± 20.0 pg/mg protein at four hours
after injury, remaining elevated through day three (10.51 ±
3.47 pg/mg protein) post-injury (Figure 1). The contralateral
cortex displayed a similar response with a significant increase
in expression (p < 0.05) of CXCL1 at four hours (26.60 ±
8.87 pg/mg protein) when compared to control tissue, which
returned to normal within 12 hours (4.38 ± 0.48 pg/mg pro-
tein post-injury). At 4, 12, and 24 hours, 1, 3, and 7 days after
injury, ipsilateral concentrations of CXCL1 were significantly
higher (p < 0.05) at all time points compared to the contralateral
cortex.
A dramatic, acute response was observed when IFN-γ was
quantified (Figure 2). In CTL, as well as samples 1, 3, and 7 days
post-injury, this cytokine was below detectable limits. However,
within four hours of injury, IFN-γ levels were approximately
(17.59 ± 4.15 pg/mg protein), declining to (3.24 ± 0.87 pg/mg
protein) at 12 hours. IFN-γ remained below detectable limits at
all time points in the contralateral cortex.
FIGURE 1 | CXCL1 (KC/GRO) concentrations increase in both the
ipsilateral and contralateral cortex following a controlled cortical
impact. Within four hours of a brain injury, CXCL1 increases (p < 0.05) in
both the ipsilateral and contralateral cortex in comparison to control. In
comparison to both control and contralateral tissue, the ipsilateral
hemisphere continued to express elevated (p < 0.05) concentrations for
three days. In contrast, the contralateral cortex only demonstrated an
elevated expression (p < 0.05) at four hours, returning to normal levels by
12 hours. All values are mean ± SEM, n = 5. ∗At each time point noted,
ipsilateral differs from control tissue, p < 0.05. ±At each time point noted,
contralateral differs from control tissue, p < 0.05. Differences between the
ipsilateral and contralateral cortices are denoted by placing the appropriate
p-value above the two bars.
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FIGURE 2 | IFN-γ concentration increases in the ipsilateral cortex four
and 12 hours following a controlled cortical impact. Within four hours of
a brain injury, IFN-γ increases (p < 0.05) in the ipsilateral cortex in
comparison to both control and contralateral tissue. At all time points, IFN-γ
was below detectable limits (BDL) in both the control and contralateral
tissue. Within 24 hours of the injury, IFNγ concentrations returned to below
detectable limits. All values are mean ± SEM, n = 5. Since IFNγ in both
control and contralateral tissue were below detectable limits, no statistical
analyses were performed.
TNF-α also demonstrated a rapid response four hours after
injury, increasing to (58.34 ± 7.82 pg/mg protein) in comparison
to both the control (4.95 ± 1.34 pg/mg protein) and contralateral
(6.66 ± 1.41 pg/mg protein) cortex (Figure 3). At 12 hours after
the injury, TNF-α concentration (15.99 ± 1.80 pg/mg protein)
remained significantly (p < 0.05) elevated in contrast to con-
trol, although due to a non-significant increase in the contralat-
eral cortex (8.00 ± 5.46 pg/mg protein), the difference between
the two ipsi- and contralateral cortices became non-significant
(p > 0.05).
A more spatially generalized response was observed when
interleukin-13 (IL-13) was quantified (Figure 4). At four hours,
in both ipsilateral (0.68 ± 0.08 pg/mg protein) and contralateral
(0.42 ± 0.13 pg/mg protein) cortices, IL-13 was significantly (p <
0.05) elevated in comparison to control tissue, and remained
elevated at 12 hours. After one day, IL-13 in the contralateral cor-
tex (0.15 ± 0.07 pg/mg protein) returned to control levels, while
slightly elevated IL-13 concentrations (0.22 ± 0.05 pg/mg pro-
tein) continued to register in the ipsilateral cortex. At both three
and seven days post-injury, neither ipsilateral nor contralateral
cortices of the brain contained statistically significantly elevated
(p > 0.05) IL-13 levels in comparison to control.
At 4 (1.01 ± 0.14 pg/mg protein), 12 (0.53 ± 0.06 pg/mg pro-
tein), and 24 (0.63 ± 0.17 pg/mg protein) hours after injury,
FIGURE 3 | TNF-α concentration increases in the ipsilateral cortex
following a controlled cortical impact. Within four hours of a brain injury,
TNF-α increases (p < 0.05) in the ipsilateral cortex in comparison to both
control and contralateral tissue. TNF-α remained elevated for the first
24 hours following injury, before returning to control levels at three days,
post-injury. In contrast, the contralateral cortex did not demonstrate an
increase in TNF-α expression at any time point in comparison to control. All
values are mean ± SEM, n = 5. ∗At each time point noted, ipsilateral differs
from control tissue, p < 0.05. ±At each time point noted, contralateral differ
from control tissue, p < 0.05. Differences between the ipsilateral and
contralateral cortices are denoted by placing the appropriate p-value above
the two bars.
interleukin-4 (IL-4) was elevated (Figure 5, p < 0.05) in the
ipsilateral, but not (p > 0.05) contralateral cortex at those same
time points (0.64 ± 0.18, 0.31 ± 0.03, and 0.51 ± 0.08 pg/mg
protein, respectively). Within three days of injury, IL-4 concen-
trations in the ipsilateral cortex were not statistically significantly
different from concentrations in control cortex.
DELAYED CYTOKINE CORTICAL RESPONSE TO TRAUMATIC
BRAIN INJURY
In contrast to the acute response observed (within four hours of
brain injury), the appearance of several cytokines took consider-
ably longer to develop. Within four hours of injury, chemokine
C-C motif ligand 2 (CCL2) was elevated (p < 0.05; 913.91 ±
91.49 pg/mg protein) in comparison to both control (14.68 ±
0.96 pg/mg protein) and the contralateral (188.21 ± 77.56 pg/mg
protein) cortex (Figure 6). However, the peak concentration of
CCL2 did not occur until 12 hours post-injury (1333.39 ±
154.48 pg/mg protein) and remained elevated throughout the
remainder of the study. At every time point measured, the ipsi-
lateral cortex contained a greater concentration of CCL2 than the
contralateral cortex. The contralateral cortex was elevated four
hours after injury, displayed no distinct peak, and returned to
levels not statistically significantly different from control levels at
three days after injury.
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FIGURE 4 | IL-13 concentration increases in both the ipsilateral and
contralateral cortex following a controlled cortical impact. Within four
hours of a brain injury, TNF-α increases (p < 0.05) in both the ipsilateral and
contralateral cortex in comparison to control tissue. There was no
difference (p > 0.05) in the ipsilateral and contralateral hemispheres at any
time point measured. However, while the contralateral returned to levels no
different from control (p > 0.05) within 24 hours, the IL-13 remained
elevated (p < 0.05) in comparison to control until three days post-injury. All
values are mean ± SEM, n = 5. ∗At each time point noted, ipsilateral differs
from control tissue, p < 0.05. ±At each time point noted, contralateral
differs from control tissue, p < 0.05.
Chemokine C-C motif ligand 20 (CCL20) also demon-
strated a delayed onset of maximum concentration (Figure 7).
Within four hours of injury, the ipsilateral cortex (13.62 ±
2.04 pg/mg protein) was significantly elevated (p < 0.05) in
comparison to both the control (1.14 ± 0.16 pg/mg protein)
and contralateral (3.99 ± 1.91 pg/mg protein) cortex. However,
peak concentration was not observed in the ipsilateral cortex
until one day post-injury (55.82 ± 14.22 pg/mg protein). At no
time point did the contralateral cortex express elevated CCL20
(p > 0.05).
IL-1b similar to IL-4, was elevated (p < 0.05) at four hours
(17.17 ± 2.37 pg/mg protein) post-injury and remained elevated
(p < 0.05) at both 12 hours (12.09 ± 1.64 pg/mg protein) and
one day (17.44 ± 4.49 pg/mg protein) in comparison to control
(Figure 8). At each of these time points, the ipsilateral cortex
was significantly elevated (p < 0.05) compared to the contralat-
eral cortex. IL-1b was elevated at four hours in the contralateral
cortex (3.41 ± 0.58 pg/mg protein), but by 12 hours, the level
(0.97 ± 0.26 pg/mg protein) was not significantly different from
observed levels in naïve controls.
Interleukin-5 (IL-5) concentration levels, in contrast to all
other tested cytokines, was not statistically significantly different
in either ipsilateral cortical tissue as compared to contralateral
FIGURE 5 | IL-4 concentration increases in the ipsilateral cortex
following a controlled cortical impact. Within four hours of a brain injury,
and persisting for 24 hours, IL-4 increases (p < 0.05) in the ipsilateral cortex
in comparison to control tissue. There was no difference (p > 0.05)
between the ipsilateral and contralateral hemispheres at any time point
measured. All values are mean ± SEM, n = 5. ∗At each time point noted,
ipsilateral differs from control tissue, p < 0.05.
tissue, or in either side as compared to naïve cortical tissue at all
time points measured during this study (Figure 9).
DISCUSSION
We report here that TBI via CCI on one brain hemisphere results
in early and later responses in specific chemokines and cytokines
in cortical tissue. Furthermore, we find that there is a differen-
tial discrimination with respect to the responses in the damaged
ipsilateral versus the undamaged contralateral cortex. This is
consistent with our hypothesis that combinations of beneficial,
neutral, and deleterious inflammatory responses occur in dis-
tinct temporal and anatomical-dependent manners after TBI. In
general, we observed significant increases in eight of the nine
analytes studied, compared to levels measured in the uninjured
naïve cortical tissue. More specifically, TBI caused early activa-
tion of TNF-α, CXCL1, and IFN-γ, with a later activation of CCL2
and CCL-20. Significantly, specific inflammatory chemokines and
cytokines peaked at time points consistent with their known
roles in a pathogen-mediated inflammatory cascade. For exam-
ple, CXCL1 (KC/GRO) and TNF-α are early stimuli responsive
pro-inflammatory mediators, and their peak levels (increasing
∼236-fold and ∼18-fold compared to control concentrations,
respectively) occur at the earliest time point in this study (four
hours post-injury).
TBI CAUSES EARLY ACTIVATION OF CXCL1, IFN-γ, TNF-α, AND IL-13
Functionally, both CXCL1 and TNF-α have biological relevance
to outcomes in TBI. CXCL1, CXCL2, and CXCL8 are related
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FIGURE 6 | CCL2 concentrations increase in both the ipsilateral and
contralateral cortex following a controlled cortical impact. Within four
hours of a brain injury, CCL2 increases (p < 0.05) in both the ipsilateral and
contralateral cortex in comparison to control. In comparison to both control
and contralateral tissue, the ipsilateral hemisphere continued to express
elevated (p < 0.05) concentrations for seven days. In contrast, the
contralateral cortex only demonstrated an elevated expression in
comparison to control (p < 0.05) at 4, 12, and 24 hours, returning to normal
levels by three days after injury. All values are mean ± SEM, n = 5. ∗At
each time point noted, ipsilateral differs from control tissue, p < 0.05. ±At
each time point noted, contralateral differs from control tissue, p < 0.05.
Differences between the ipsilateral and contralateral cortices are denoted
by placing the appropriate p-value above the two bars.
ligands of the CXCR2 receptor, which are known to be signifi-
cantly expressed by neutrophils. Not surprisingly, rapid increase
in CXCR2 ligands after TBI in rodent studies is associated with
early robust infiltration of neutrophils into the area of brain tis-
sue injury (Bye et al., 2007). Consistently, recent work in CXCR2
knockout animals have demonstrated a massive reduction in neu-
trophil influx into injured brain tissue, with a correlated decrease
in lesion volume, as compared to wild-type controls (Semple
et al., 2010b). The prompt elevation of CXCL1, the rat equivalent
of CXCL8 in humans, is reminiscent of the report that CXCL8 lev-
els in the CSF of patients correlates with mortality in patients with
severe TBI (Whalen et al., 2000). Clearly, it would be of trans-
lational importance to understand CXCR ligand upregulation in
brain tissue after injury.
IFN-γ is produced by microglia and brain macrophages upon
pathogen stimulation or cellular activation (Suzuki et al., 2005;
Kawanokuchi et al., 2006). Therefore, the brief increase in IFN-γ
observed only at the earliest time point in this study suggests
that primary TBI effects may be the cause for IFN-γ produc-
tion by brain innate immune cells. Interestingly, IFN-γ plays
a functional role in early innate immunity by activation of
FIGURE 7 | CCL20 concentrations increase in the ipsilateral cortex
following a controlled cortical impact. Within four hours of a brain injury,
CCL20 increases (p < 0.05) in the ipsilateral cortex in comparison to both
control and contralateral tissue. The expression of CCL20 peaked 24 hours
after injury, and did not return to levels observed in control or contralateral
tissue until seven days post-injury. At no time, was the expression of
CCL20 observed to be elevated (p > 0.05) in the contralateral cortex in
comparison to control. All values are mean ± SEM, n = 5. ∗At each time
point noted, ipsilateral differs from control tissue, p < 0.05. Differences
between the ipsilateral and contralateral cortices are denoted by placing the
appropriate p-value above the two bars.
leukocyte adhesion and antigen presentation by microglia and
macrophages, as well as delayed adaptive immunity by promoting
a Th1 cellular response. Interestingly, blockade of IFN-γ signaling
did not alter outcome in a stab injury model study (Rostworowski
et al., 1997). Therefore, analysis of delayed outcome measures in
a TBI model with IFN-γ blockade or knockout is warranted.
TNF-α also plays a role in the initial response to tissue dam-
age, by rapidly increasing after TBI (Shohami et al., 1997). In
the present study, TNF-α peaked at four hours post-injury, but
was markedly decreased by 12 hours. From studies on direct
administration of recombinant TNF-α protein into the brain,
the functional consequence is compromise of blood-brain barrier
integrity, induction of inflammatory cascades, and promotion of
immune cell infiltration into brain parenchyma (Ramilo et al.,
1990; Kim et al., 1992). Presumably, all three consequences are
visited on the damaged cortex by the rapid increase in endoge-
nous TNF-α. Consistently, agents that act to inhibit TNF-α
activity, all result in improved neurological outcome after TBI
(Shohami et al., 1997).
The anti-inflammatory cytokine IL-13, which also peaks
within four hours of injury, is reported to reduce the produc-
tion of pro-inflammatory mediators from activated microglia
and macrophages. Macrophages reduce the expression of iNOS
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FIGURE 8 | IL-1β concentrations increase in the ipsilateral cortex
following a controlled cortical impact. Within four hours of a brain injury,
IL-1β increases (p < 0.05) in the ipsilateral cortex in comparison to both
control and contralateral tissue. The expression of IL-1β remained elevated
for the first 24 hours after injury, and did not return to levels observed in
control or contralateral tissue (p > 0.05) until three days post-injury. At no
time, was the expression of IL-1β observed to be elevated (p > 0.05) in the
contralateral cortex in comparison to control. All values are mean ± SEM,
n = 5. ∗At each time point noted, ipsilateral differs from control tissue,
p < 0.05. Differences between the ipsilateral and contralateral cortices are
denoted by placing the appropriate p-value above the two bars.
protein andmRNA following pre-treatment of IL-13, by a mecha-
nism that is antagonized by IFN-γ (Bogdan et al., 1997). Paludan
et al. (1997) also confirmed these results (Paludan et al., 1997).
This is surprising that two cytokines, IL-13 and IFN-γ, with
opposing effects would be so potently increased following a
brain injury. To understand this process, however, will require
additional investigation.
TBI CAUSES TEMPORARY INCREASES IN ANTI-INFLAMMATORY
CYTOKINE IL-4
Of the inflammatory mediators analyzed in this study, IL-4 is the
primary regulatory cytokine that possess anti-inflammatory func-
tions. We observed modest but significant increases in injured
tissue for an early time window (4–12 hours post-injury). This
finding was unexpected as previous studies of brain injury have
shown IL-4 to be below detectable levels or unchanged (Takamiya
et al., 2007). However, it is known that both astrocytes and
microglia have the capacity to produce IL-4, and this produc-
tion is increased upon activation (Hulshof et al., 2002; Ponomarev
et al., 2007). Since IL-4 has been recently appreciated to signal
alternative neuroprotective activation of microglia (Zhao et al.,
2006), the short duration increase of IL-4 after rat TBI may play
an autoregulatory role to reduce inflammatory-related damage.
FIGURE 9 | IL-5 concentrations in the ipsilateral and contralateral
cortex were not affected by a controlled cortical impact. At no time
point after the brain injury were elevated concentrations of IL-5 observed in
either the ipsilateral or contralateral cortex in comparison to control tissue
(p > 0.05). All values are mean ± SEM, n = 5.
Other anti-inflammatory mediators should be analyzed and eval-
uated in future rodent TBI studies.
TBI CAUSES A DELAYED ACTIVATION OF CCL2 AND CCL20
We also observed robust but delayed changes in the levels of
CCL2 (MCP-1) and CCL20 chemokines following early CXCL1
and TNF-α responses after CCI injury. CCL2 (MCP-1) peak lev-
els were ∼90-fold higher than uninjured healthy tissue at 12
hours post-injury and absolute CCL2 levels of approximately
1300 pg/mg protein were significantly higher than all other ana-
lytes measured. This observation supports previous information
that CCL2 is routinely measurable in brain tissue (Glabinski et al.,
1996) and cerebrospinal fluid (Semple et al., 2010a) due to both
high basal concentrations and to sensitivity to injury (Muessel
et al., 2000; Rancan et al., 2001). Our results also found that CCL2
levels remain significantly greater in injured cortex, than in unin-
jured control and contralateral tissue throughout all time points
measured (seven days). These data agree also with repeated mea-
surements for CCL2 in CSF of patients with TBI, where levels
are significantly greater than in control patients at each day post-
injury up to day 9 (Semple et al., 2010a). Furthermore, Semple
et al. (2010b) investigated the potential pathological role of CCL2
following a TBI in CCL2 knockout and wild-type mice (Semple
et al., 2010a). In support of a positive functional role for CCL2
during the secondary phase of TBI processes, the study did not
observe differences in lesion size or cell death within seven days
after brain injury, but found significant decreases in lesion vol-
ume, reactive gliosis, macrophage infiltration, and neurological
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outcome in CCL2−/− mice as compared to wild-type controls in
subjects at second and fourth weeks. Despite these data demon-
strating that lost CCL2 signaling is beneficial, it is also confirming
that CCL2 acts in chemotaxis of peripheral macrophages and the
activation of both microglia andmacrophages. Therefore, the role
of these two cell populations in the removal of cellular debris may
also serve to protect the brain from injury at specific temporal
windows. The combined impact of these reports on the response
of CCL2 to TBI suggests that CCL2 merits further testing of
potential therapeutics in preclinical rodent models of TBI.
A delayed peak level after CCI injury was also observed in anal-
ysis of CCL20 (MIP-3a). There is less known about the role of
this chemokine in the context of TBI. Of translational relevance
is the fact that CCL2 levels have been observed to be sustained
in CSF of TBI patients (Semple et al., 2010a). However, in stud-
ies of experimental autoimmune encephalomyelitis, a model for
demyelinating multiple sclerosis, astrocytes have been shown
to be the primary source of CCL20. Furthermore, the increase
in CCL20 is associated with recruitment of highly inflamma-
tory autoimmune-related Th17 cells (Ambrosini et al., 2003).
Additionally, CCL20 is responsible for B cell lymphocyte matura-
tion and antigen-mediated differentiation (Krzysiek et al., 2000).
Thus, the delayed expression of CCL20 may suggest a recruitment
of the adaptive immune response and potential autoimmunity
at this time point after CCI injury. Interestingly, CCL20 is the
sole known ligand for CCR6 and thus may provide a therapeu-
tic target for preclinical studies in TBI where minimal off-target
effects exist.
SELECTION OF ECL-BASED IMMUNOASSAY TECHNOLOGY FOR
BRAIN HOMOGENATE ANALYSIS
For this study, we selected and utilized commercially avail-
able electrochemiluminescent-based singleplex and multiplex
immunoassays for profiling inflammatory chemokines and
cytokines in rat brain homogenates. The selection of this type
of assay was due to advantages in linear dynamic range, preci-
sion, lower limits of detection, and low sample volume require-
ments as compared to the other surveyed assays (conventional
ELISA, reverse phase capture array, bead-based multiplex assay).
Comparative analysis of this assay technology with others sur-
veyed has been described in previous studies by other laboratories
with similar conclusions (Chowdhury et al., 2009; Fu et al., 2010).
In summary, this study provides a framework for determin-
ing the levels of inflammatory mediators in rat brain tissue
homogenates, provides key information to aid in the selection
of analytes as an early and delayed phase outcome measure
in preclinical studies of TBI, and supports the hypothesis that
rapid and potent inflammatory responses in injured brain tis-
sue are also associated with delayed and robust responses that
could mediate recruitment of the adaptive immune response.
Whether activation of the adaptive immune response aids in
brain tissue repair or further damage is not clear. There is
potential for the use of select chemokines and cytokines for
biomarkers in clinical TBI and, therefore, further study of the
modulation and functional role of these inflammatory medi-
ators in rodent models (including genetic knockout subjects)
in TBI is warranted. Finally, a thorough review of the litera-
ture reveals a number of excellent studies examining changes in
cytokine expression at 24 hours or more after injury, includ-
ing a recent study confirming observed increases in TNF-α and
CCL-2 levels using two independent techniques. These authors
suggest that by neglecting earlier time points, within just hours
of injury, potentially invaluable data is not being captured
given the transient response in cytokine expression observed
here. Our analysis of cytokine expression using an indepen-
dent high sensitivity two antibody electrochemiluminescence-
based ELISA methodology provides further validation that
these changes are occurring in the brain parenchyma after
injury.
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